KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Viatris (VTRS) Research & Development (2020 - 2026)

Viatris has reported Research & Development over the past 6 years, most recently at $274.7 million for Q4 2025.

  • For Q4 2025, Research & Development rose 33.03% year-over-year to $274.7 million; the TTM value through Dec 2025 reached $965.9 million, up 19.44%, while the annual FY2025 figure was $965.9 million, 19.44% up from the prior year.
  • Research & Development for Q4 2025 was $274.7 million at Viatris, up from $250.4 million in the prior quarter.
  • Over five years, Research & Development peaked at $274.7 million in Q4 2025 and troughed at $142.3 million in Q1 2022.
  • A 5-year average of $196.1 million and a median of $199.0 million in 2024 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: skyrocketed 75.51% in 2021 and later dropped 22.71% in 2022.
  • Year by year, Research & Development stood at $197.1 million in 2021, then fell by 7.46% to $182.4 million in 2022, then increased by 11.18% to $202.8 million in 2023, then increased by 1.82% to $206.5 million in 2024, then skyrocketed by 33.03% to $274.7 million in 2025.
  • Business Quant data shows Research & Development for VTRS at $274.7 million in Q4 2025, $250.4 million in Q3 2025, and $218.8 million in Q2 2025.